Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 10.34 BATS BZX Real-Time Price As of 12:42pm ET |  -0.10 / -0.96%Today’s Change | 2.05 Today|||52-Week Range 15.00 | +169.27% Year-to-Date |
Latest ALPN News | Press Releases
| Alpine Immune Sciences secures equity capital of $60M Jul 24 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 10.44 |
| Today’s open | 10.22 |
| Day’s range | 10.03 - 10.34 |
| Volume | 2,463 |
| Average volume (3 months) | 591,621 |
| Market cap | $191.7M |
Data as of 12:42pm ET, 08/11/2020
Growth & Valuation
| Earnings growth (last year) | +13.47% |
| Earnings growth (this year) | +72.51% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +146.81% |
| P/E ratio | NM |
| Price/Sales | 40.52 |
| Price/Book | 6.50 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NCNANuCana PLC | +0.21 | +3.55% |
| TLCTaiwan Liposome Co L... | -0.09 | -1.70% |
| AXLAAxcella Health Inc | +0.27 | +5.16% |
| MREOMereo BioPharma Grou... | -0.02 | -0.69% |
Data as of 1:34pm ET, 08/11/2020
Financials
| Next reporting date | August 12, 2020 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $1.7M |
| Annual profit (last year) | -$41.9M |
| Net profit margin | -2,405.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
